Phase 3 double-blind placebo-controlled randomized trial of Z-100 in patients with radiation therapy for cervical cancer

INTERVENTION: Intervention name : Z‐100 Dosage And administration of the intervention : Injection CONDITION: Primary cervical cancer patients treated with radiotherapy PRIMARY OUTCOME: Survival INCLUSION CRITERIA: INCLUSION CRITERIA: ‐Patients with FIGO Stage IIb ‐ IVa. ‐Patients with squamous cell carcinoma histologically. Exclusion Criteria: ‐Patients with complication of cancers in addition to cervical cancer or patients who undergo the therapy. ‐Patients who contracted the cancers except for cervical cancer within 5 years.